Public recall detail

Unauthorized drug (Lite Fit USA) being sold in Canada

medium
Recall Safety notice
Quick summary

Quick summary: Unauthorized drug (Lite Fit USA) being sold in Canada .

Recommended action

Recommended action: compare your product with the official notice and follow the instructions published by the official source.

Recall details

Quick summary: Unauthorized drug (Lite Fit USA) being sold in Canada .

Official details

Affected product details

Structured information extracted from the official recall notice. Confirm the identifiers and instructions in the original notice.

Brand

Issue

One lot of Lite Fit USA (Lot Number 13165, Exp. 05/17) is being voluntarily recalled in the U.S. after analysis by the U.S. Food and Drug Administration revealed the lot contains the undeclared prescription drug sibutramine. Lite Fit USA is not authorized for sale in Canada, but Health Canada has confirmed that this lot was imported and sold by the retail store Hoang Oanh Sandwich, 7178 St. Denis, Montreal, Québec. The affected lot may also be available at other retail outlets or for purchase online. Products that contain sibutramine are not authorized for sale on the Canadian market due to an increased risk of heart attack and stroke. LiteFit USA is promoted as a herbal diet supplement packaged in plastic bottles of 30 softgels (see photo below).

What you should do

  • Read the label of the products you buy to verify that they have been assessed by Health Canada for safety, effectiveness and quality. Health products that have been authorized for sale by Health Canada will have an eight-digit Drug Identification Number (DIN), a Homeopathic Medicine Number (DIN-HM) or a Natural Product Number (NPN) on the label.
  • Contact your health care practitioner if you have any questions or concerns regarding the use of this product.
  • Report any adverse events using these products to Health Canada.
Additional official information
Background{"text":"Sibutramine was previously used to treat obesity but is no longer authorized for sale in Canada because of its association with an increased risk of cardiovascular side-effects such as heart attack and stroke. The product poses a risk to consumers because sibutramine is known to substantially increase blood pressure and/or pulse rate in some patients and may present a significant risk for patients with a history of cardiovascular disease including coronary artery disease, congestive heart failure, arrhythmias, or stroke. This product may also cause serious side-effects in pregnant or nursing women. Sibutramine can interact with other medications and herbal products and poses a risk of serotonin syndrome, a serious and potentially fatal event. Health Canada has not received any adverse reactions reports associated with the use of this product."}
Companies
Audiences

Contains information licensed under the Open Government Licence – Canada. SafetyPulse is independent of the Government of Canada.

Official source Monitor products Back to recalls

Starting...

Related recalls

Similar recalls and safety notices.

Loading related recalls...